Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma
The episode discusses the link between gut microbiota diversity and mortality in pediatric allogeneic transplant recipients. It also covers complement inhibition for atypical hemolytic uremic syndrome and the effectiveness of PD-1 and HDAC inhibitors in treating refractory…